glp-1 advertising crackdown news FEDS CRACK DOWN ON TELEHEALTH COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight FDA issued 25 warning letters

And I would say any compounding pharmacy or outsourcing facility that continues to prepare copies of tirzepatide injection after today are putting themselves in a certain amount of legal risks, Brunner said to CNBC

Keep in mind that your Medicare Part D plan either a PDP or an MA-PD cannot provide any coverage for a GLP-1 if its prescribed for weight loss (unless its an enhanced alternative coverage plan, as described above)

After it was issued, he tried to drum up interest with the big name diabetes drugmakers at the time, including Eli Lilly, Bristol Myers Squibb, Sanofi, and Novo Nordisk

Their hormonal systems have adapted to lower insulin environments